NCT00005626View on ClinicalTrials.gov

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
LeukemiaLymphoma
Interventions
DRUG

Irinotecan

Irinotecan as outlined in treatment arm

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

Upjohn
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Upjohn

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER